![Thomas P. Blackburn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas P. Blackburn
Direttore/Membro del Consiglio presso Umecrine Cognition AB
Provenienza dei contatti di primo grado di Thomas P. Blackburn
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Umecrine Cognition AB
![]() Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Thomas P. Blackburn tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Svenska Vaccinfabriken Produktion AB
![]() Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Modus Therapeutics AB
![]() Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Chief Executive Officer | |
AnaCardio AB
![]() AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member | |
CAREDX, INC | Medical Specialties | Corporate Officer/Principal | |
DIAMYD MEDICAL AB | Pharmaceuticals: Major | Director/Board Member | |
Umea Universitet | College/University | Corporate Officer/Principal | |
Obstetrics & Gynecology, Inc.
![]() Obstetrics & Gynecology, Inc. Medical/Nursing ServicesHealth Services Obstetrics & Gynecology, Inc. engages in providing obstetrics and gynecology (ObGyn) and women's health services. The company is headquartered in St. Louis, MO. | Medical/Nursing Services | Corporate Officer/Principal | |
Umecrine AB
![]() Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Biotechnology | Founder | |
IDOGEN AB (PUBL) | Biotechnology | Chief Executive Officer | |
Novartis Sverige AB
![]() Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Novartis Sverige AB trades pharmaceutical products. It offers products for the treatment of ADHD, multiple sclerosis, urticaria, allergic asthma, psoriasis, chronic obstructive pulmonary disorder, migraine, blood diseases, eye disorder, and other diseases. The company is headquartered in Kista, Sweden. | Pharmaceuticals: Major | Sales & Marketing | |
Henley Business School Ltd. | College/University | Masters Business Admin | |
AIK FOTBOLL AB | Movies/Entertainment | Director of Finance/CFO | |
CareDx AB
![]() CareDx AB Medical SpecialtiesHealth Technology CareDx AB develops reagents and kits for low and high resolution human leukocyte antigen typing. Its products include Olerup SSP, Olerup QTYPE, Olerup XM-ONE, Olerup SBT and Olerup Gamma-Type. The comaony was founded by Olle Olerup in 1992 and is headquartered in Saltsjobaden, Sweden. | Medical Specialties | Chief Executive Officer | |
Novartis Norge AS
![]() Novartis Norge AS Miscellaneous Commercial ServicesCommercial Services Novartis Norge AS develops, markets, and trades pharmaceuticals. It offers ophthalmic and generic products. The company is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Chief Executive Officer | |
Olerup GmbH
![]() Olerup GmbH Pharmaceuticals: MajorHealth Technology Part of CareDx, Inc., Olerup GmbH develops reagents, diagnostic and genotyping kits for transplantation. The company is based in Vienna, Austria. The CEO of the Austrian company is Anders Eric Karlsson. | Pharmaceuticals: Major | Chief Executive Officer | |
CareDx Lab Solutions, Inc.
![]() CareDx Lab Solutions, Inc. Medical SpecialtiesHealth Technology Part of CareDx, Inc., CareDx Lab Solutions, Inc. develops reagents and kits for low and high resolution human leukocyte antigen typing. The company is based in West Chester, PA. The CEO of the company is Anders Eric Karlsson. | Medical Specialties | Chief Executive Officer | |
CareDx International (Private Equity)
![]() CareDx International (Private Equity) Investment ManagersFinance Allenex (Private Equity) (Allnex PE) is the private equity division of LinkMed AB (ST: LMED) in Sweden. Located in Stockholm, the firm was formerly known as LinkMed Private Equity, founded by Ingemar Lagerlöf in 1998. To assure the continued growth of their investee companies, Allnex PE has assembled a network of medical and managerial resources, divided into Corporate Operational Functions (Board and Management Team) and the Venture Management Network (Business Network and Scientific Advisory Board). The Venture Management Network provides guidance and strategic expertise to investee companies. | Investment Managers | Chief Executive Officer | |
ALLENEX AB | Biotechnology | Chief Executive Officer | |
ASARINA PHARMA AB | Pharmaceuticals: Major | Founder | |
Umeå Neurosteroid Research | Corporate Officer/Principal | ||
University of Lund | College/University | Doctorate Degree | |
IMED AB
![]() IMED AB Drugstore ChainsRetail Trade IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies. | Drugstore Chains | Chief Executive Officer | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Linköping
![]() University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Doctorate Degree | |
MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Stockholm School of Economics | College/University | Masters Business Admin | |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Journal of Clinical Investigation
![]() The Journal of Clinical Investigation Miscellaneous Commercial ServicesCommercial Services The Journal of Clinical Investigation is a private company headquartered in Ann Arbor, MI. The firm operates as non-profit organization of physician-scientists. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Society for Clinical Investigation
![]() American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Biotechnology | President | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
Seqirus Vaccines Ltd.
![]() Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
Novartis Vaccines & Diagnostics, Inc.
![]() Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | President | |
Olerup International AB
![]() Olerup International AB BiotechnologyHealth Technology Olerup International AB distributes molecular diagnostic products and services for human leukocyte antigen (HLA) typing and antibody detection. It offers transplant diagnostics and supportive software. The firm provides products and services for bone marrow and organ transplantation. Its HLA portfolio consists of two product lines, Sequence Specific Primer Genomic HLA Typing and Sequencing Based Typing. The company was founded in 2009 and is headquartered in Stockholm, Sweden. | Biotechnology | Chief Executive Officer | |
Neoventa Medical AB
![]() Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Medical Specialties | Director/Board Member | |
Karolinska Development AB (Private Equity)
![]() Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer | |
Avidicare Holding AB
![]() Avidicare Holding AB Medical SpecialtiesHealth Technology Avidicare Holding AB provides digital services through its opragon platform and a range of customizable services. Customers can purchase from the Swedish company by contacting their sales directors or CEO, whose contact details are available on their website. | Medical Specialties | Corporate Officer/Principal | |
Airsonett Holding AB | Director/Board Member | ||
Scibase Intressenter AB | Chairman | ||
InDex Diagnostics AB
![]() InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Chairman | |
Scibase AB | Director/Board Member |
Statistiche
Distribuzione geografica
Svezia | 35 |
Stati Uniti | 12 |
Sud Africa | 2 |
Norvegia | 2 |
Austria | 2 |
Settori
Health Technology | 29 |
Consumer Services | 9 |
Commercial Services | 5 |
Finance | 4 |
Health Services | 2 |
Posizioni
Director/Board Member | 42 |
Chief Executive Officer | 17 |
Corporate Officer/Principal | 15 |
Chairman | 9 |
Chief Tech/Sci/R&D Officer | 8 |
Contatti più connessi
- Borsa valori
- Insiders
- Thomas P. Blackburn
- Connessioni Società